Moreover, CNIH4 has been shown to be significantly overexpressed in LIHC tissues and is significantly associated with gastric cancer cell proliferation, proposing it as a novel biomarker for ovarian cancer (Zhang et al., 2023; Wang et al., 2021; Kasavi, 2022). Here, CNIH4 is linked to ovarian cancer.